Aaron M Norr1, Derek J Smolenski2, Greg M Reger3. 1. VA Puget Sound Health Care System, Tacoma/Seattle, WA, USA; University of Washington School of Medicine, Seattle, WA, USA. 2. Defense Health Agency, Psychological Health Center of Excellence, Tacoma, WA, USA. 3. VA Puget Sound Health Care System, Tacoma/Seattle, WA, USA; University of Washington School of Medicine, Seattle, WA, USA. Electronic address: Greg.Reger@va.gov.
Abstract
OBJECTIVE: The current study sought to investigate the effects of exposure therapy on suicidal ideation (SI), as well as potential mechanistic pathways of SI reduction among active duty military personnel. METHODS:Active duty army soldiers (N = 162) were recruited from a military base in the U.S. and were enrolled in a randomized clinical trial comparing Prolonged Exposure (PE), Virtual Reality Exposure (VRE), and a wait-list control for the treatment of posttraumatic stress disorder (PTSD) stemming from deployments to Iraq or Afghanistan. PTSD diagnosis followed DSM-IV-TR criteria. Outcome measures were assessed via self-report and clinician interview. PTSD symptoms, depressive symptoms, and SI were included in an autoregressive cross-lagged panel model to examine mechanistic pathways. RESULTS: Analyses revealed that PE/VRE had a lower probability of post-treatment suicidal ideation (OR = 0.23, 95% CI [0.06, 0.86]) compared to the waitlist control. Mediation analyses revealed a significant indirect effect from treatment condition to post-treatment PTSD symptoms through mid-treatment SI (Estimate = -1.420, 95% CI -3.559, -0.223]). Baseline suicidal ideation did not interact with treatment condition to predict PTSD symptom change at mid-treatment (p = .231) or post-treatment (p = .672). CONCLUSION:PE/VRE successfully reduced SI, and the presence of SI at baseline did not affect PTSD symptom reduction, promoting the utility of using PE/VRE to address suicidality among individuals with PTSD. Mediation analyses suggest that reductions in SI were achieved early in treatment. Published by Elsevier Ltd.
RCT Entities:
OBJECTIVE: The current study sought to investigate the effects of exposure therapy on suicidal ideation (SI), as well as potential mechanistic pathways of SI reduction among active duty military personnel. METHODS: Active duty army soldiers (N = 162) were recruited from a military base in the U.S. and were enrolled in a randomized clinical trial comparing Prolonged Exposure (PE), Virtual Reality Exposure (VRE), and a wait-list control for the treatment of posttraumatic stress disorder (PTSD) stemming from deployments to Iraq or Afghanistan. PTSD diagnosis followed DSM-IV-TR criteria. Outcome measures were assessed via self-report and clinician interview. PTSD symptoms, depressive symptoms, and SI were included in an autoregressive cross-lagged panel model to examine mechanistic pathways. RESULTS: Analyses revealed that PE/VRE had a lower probability of post-treatment suicidal ideation (OR = 0.23, 95% CI [0.06, 0.86]) compared to the waitlist control. Mediation analyses revealed a significant indirect effect from treatment condition to post-treatment PTSD symptoms through mid-treatment SI (Estimate = -1.420, 95% CI -3.559, -0.223]). Baseline suicidal ideation did not interact with treatment condition to predict PTSD symptom change at mid-treatment (p = .231) or post-treatment (p = .672). CONCLUSION: PE/VRE successfully reduced SI, and the presence of SI at baseline did not affect PTSD symptom reduction, promoting the utility of using PE/VRE to address suicidality among individuals with PTSD. Mediation analyses suggest that reductions in SI were achieved early in treatment. Published by Elsevier Ltd.
Authors: Shannon M Blakey; Sarah C Griffin; Jeremy L Grove; Samuel C Peter; Ryan D Levi; Patrick S Calhoun; Eric B Elbogen; Jean C Beckham; Mary J Pugh; Nathan A Kimbrel Journal: J Affect Disord Date: 2022-04-07 Impact factor: 6.533
Authors: Noelle B Smith; Lauren M Sippel; David C Rozek; Patricia T Spangler; Delphine Traber; Casey L Straud; Rani Hoff; Ilan Harpaz-Rotem Journal: Depress Anxiety Date: 2020-01-17 Impact factor: 6.505
Authors: Aaron M Norr; Andrea C Katz; Janelle L Nguyen; Keren Lehavot; Norman B Schmidt; Greg M Reger Journal: Psychiatry Res Date: 2020-08-17 Impact factor: 3.222